{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T22:10:55Z","timestamp":1789855855105,"version":"4.0.1"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T00:00:00Z","timestamp":1511481600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00404-017-4594-3","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T10:28:28Z","timestamp":1511519308000},"page":"241-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation"],"prefix":"10.1007","volume":"297","author":[{"given":"A. N.","family":"Sch\u00fcring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Fehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Behringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Goeckenjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wimberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Henes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Henes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Fey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"von Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,24]]},"reference":[{"key":"4594_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-015-0545-7","volume":"14","author":"M Lambertini","year":"2016","unstructured":"Lambertini M, Del Mastro L, Pescio MC, Andersen CY, Azim HA Jr, Peccatori FA, Costa M, Revelli A, Salvagno F, Gennari A, Ubaldi FM, La Sala GB, De Stefano C, Wallace WH, Partridge AH, Anserini P (2016) Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med 14:1. https:\/\/doi.org\/10.1186\/s12916-015-0545-7","journal-title":"BMC Med"},{"key":"4594_CR2","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1200\/JCO.2013.49.2678","volume":"31","author":"AW Loren","year":"2013","unstructured":"Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K, American Society of Clinical Oncology (2013) Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2500\u20132510. https:\/\/doi.org\/10.1200\/JCO.2013.49.2678","journal-title":"J Clin Oncol"},{"key":"4594_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00404-011-1874-1","volume":"284","author":"M Wolff von","year":"2011","unstructured":"von Wolff M, Montag M, Dittrich R, Denschlag D, Nawroth F, Lawrenz B (2011) Fertility preservation in women\u2014a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin\u2019s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet 284:427\u2013435. https:\/\/doi.org\/10.1007\/s00404-011-1874-1","journal-title":"Arch Gynecol Obstet"},{"key":"4594_CR4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jamcollsurg.2008.12.001","volume":"208","author":"JL Gnerlich","year":"2009","unstructured":"Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA (2009) Elevated breast cancer mortality in women younger than age 40\u00a0years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg 208:341\u2013347","journal-title":"J Am Coll Surg"},{"key":"4594_CR5","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/annonc\/mdq072","volume":"21","author":"G Cancello","year":"2010","unstructured":"Cancello G, Maisonneuve P, Rotmensz N, Viale G, Mastropasqua MG, Pruneri G, Veronesi P, Torrisi R, Montagna E, Luini A, Intra M, Gentilini O, Ghisini R, Goldhirsch A, Colleoni M (2010) Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<\u00a035\u00a0years) with operable breast cancer. Ann Oncol 21:1974\u20131981","journal-title":"Ann Oncol"},{"key":"4594_CR6","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","volume":"26","author":"CK Anders","year":"2008","unstructured":"Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26:3324\u20133330. https:\/\/doi.org\/10.1200\/JCO.2007.14.2471","journal-title":"J Clin Oncol"},{"key":"4594_CR7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10549-009-0388-z","volume":"119","author":"W Han","year":"2010","unstructured":"Han W, Kang SY, Korean Breast Cancer Society (2010) Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35\u00a0years is a reasonable cut-off for defining young age-onset breast cancer. Clin Breast Cancer Res Treat 119:193\u2013200","journal-title":"Clin Breast Cancer Res Treat"},{"key":"4594_CR8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/oxfordjournals.annonc.a057718","volume":"1","author":"A Goldhirsch","year":"1990","unstructured":"Goldhirsch A, Gelber RD, Castiglione M (1990) The magnitude of endocrine effects of adjuvant chemotherapy for premeno- pausal breast cancer patients: the International Breast Cancer Study Group. Ann Oncol 1:183\u2013188","journal-title":"Ann Oncol"},{"key":"4594_CR9","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1002\/cncr.25106","volume":"116","author":"P Sukumvanich","year":"2010","unstructured":"Sukumvanich P, Case LD, Van Zee K, Singletary SE, Paskett ED, Petrek JA, Naftalis E, Naughton MJ (2010) Incidence and time course of bleeding after longterm amenorrhea after breast cancer treatment: a prospective study. Cancer 116:3102\u20133111","journal-title":"Cancer"},{"key":"4594_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv202","author":"NC Llarena","year":"2015","unstructured":"Llarena NC, Estevez SL, Tucker SL, Jeruss JS (2015) Impact of fertility concerns on tamoxifen initiation and persistence. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv202","journal-title":"J Natl Cancer Inst"},{"key":"4594_CR11","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.3747\/co.22.2338","volume":"22","author":"J Raphael","year":"2015","unstructured":"Raphael J, Trudeau ME, Chan K (2015) Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature. Curr Oncol 22:S8\u2013S18. https:\/\/doi.org\/10.3747\/co.22.2338","journal-title":"Curr Oncol"},{"key":"4594_CR12","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/humrep\/dep196","volume":"24","author":"M Sanchez-Serrano","year":"2009","unstructured":"Sanchez-Serrano M, Novella-Maestre E, Rosello-Sastre E, Camarasa N, Teruel J, Pellicer A (2009) Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation. Hum Reprod 24:2238\u20132243","journal-title":"Hum Reprod"},{"key":"4594_CR13","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.fertnstert.2010.12.019","volume":"95","author":"M Rosendahl","year":"2011","unstructured":"Rosendahl M, Timmermans Wielenga V, Nedergaard L, Kristensen SG, Ernst E, Rasmussen PE, Anderson M, Schmidt KT, Andersen CY (2011) Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer. Fertil Steril 95:2158\u20132161","journal-title":"Fertil Steril"},{"key":"4594_CR14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.fertnstert.2014.11.001","volume":"103","author":"EJ Hoekman","year":"2015","unstructured":"Hoekman EJ, Smit VT, Fleming TP, Louwe LA, Fleuren GJ, Hilders CG (2015) Searching for metastases in ovarian tissue before autotransplantation: a tailor-made approach. Fertil Steril 103:469\u2013477","journal-title":"Fertil Steril"},{"key":"4594_CR15","doi-asserted-by":"publisher","first-page":"e0168277","DOI":"10.1371\/journal.pone.0168277","volume":"12","author":"IT Peters","year":"2017","unstructured":"Peters IT, van Zwet EW, Smit VT, Liefers GJ, Kuppen PJ, Hilders CG, Trimbos JB (2017) Prevalence and risk factors of ovarian metastases in breast cancer patients\u00a0<\u00a041 years of age in the Netherlands: a nationwide retrospective cohort study. PLoS One 12:e0168277. https:\/\/doi.org\/10.1371\/journal.pone.0168277 (eCollection 2017)","journal-title":"PLoS One"},{"key":"4594_CR16","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s10815-013-0065-3","volume":"30","author":"V Luyckx","year":"2013","unstructured":"Luyckx V, Durant JF, Camboni A, Gilliaux S, Amorim CA, Van Langendonckt A, Irenge LM, Gala JL, Donnez J, Dolmans MM (2013) Is transplantation of cryopreserved ovarian tissue from patients with advanced-stage breast cancer safe? A pilot study. J Assist Reprod Genet 30:1289\u20131299. https:\/\/doi.org\/10.1007\/s10815-013-0065-3","journal-title":"J Assist Reprod Genet"},{"key":"4594_CR17","doi-asserted-by":"publisher","first-page":"374012","DOI":"10.1155\/2011\/374012","volume":"2011","author":"O Bougie","year":"2011","unstructured":"Bougie O, Weberpals JI (2011) Clinical considerations of BRCA1- and BRCA2- mutation carriers: a review. Int J Surg Oncol 2011:374012. https:\/\/doi.org\/10.1155\/2011\/374012","journal-title":"Int J Surg Oncol"},{"key":"4594_CR18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","volume":"100","author":"A Finch","year":"2006","unstructured":"Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ (2006) Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gyneco Oncol 100:58\u201364","journal-title":"Gyneco Oncol"},{"key":"4594_CR19","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S1470-2045(15)00049-2","volume":"16","author":"J Bernhard","year":"2015","unstructured":"Bernhard J, Luo W, Ribi K, Colleoni M, Burstein HJ, Tondini C, Pinotti G, Spazzapan S, Ruhstaller T, Puglisi F, Pavesi L, Parmar V, Regan MM, Pagani O, Fleming GF, Francis PA, Price KN, Coates AS, Gelber RD, Goldhirsch A, Walley BA (2015) Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase-III randomized trials. Lancet Oncol 16:848\u2013858","journal-title":"Lancet Oncol"},{"key":"4594_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/humrep\/dex027","volume":"32","author":"RJ Rodgers","year":"2017","unstructured":"Rodgers RJ, Reid GD, Koch J, Deans R, Ledger WL, Friedlander M, Gilchrist RB, Walters KA, Abbott JA (2017) The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review. Hum Reprod 32:1033\u20131045. https:\/\/doi.org\/10.1093\/humrep\/dex027","journal-title":"Hum Reprod"},{"key":"4594_CR21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jamcollsurg.2009.08.006","volume":"209","author":"J Baynosa","year":"2009","unstructured":"Baynosa J, Westphal LM, Madrigrano A, Wapnir I (2009) Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation. J Am Coll Surg 209:603\u2013607. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2009.08.006","journal-title":"J Am Coll Surg"},{"issue":"488\u2013495","key":"4594_CR22","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.fertnstert.2014.05.017","volume":"102","author":"D Meirow","year":"2014","unstructured":"Meirow D, Raanani H, Maman E, Paluch-Shimon S, Shapira M, Cohen Y, Kuchuk I, Hourvitz A, Levron J, Mozer-Mendel M, Brengauz M, Biderman H, Manela D, Catane R, Dor J, Orvieto R, Kaufman B (2014) Tamoxifen co-administration during controlled ovarian hyperstimulation for in\u00a0vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies. Fertil Steril 102(488\u2013495):e3. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.05.017","journal-title":"Fertil Steril"},{"key":"4594_CR23","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3109\/09513590.2013.819083","volume":"29","author":"A Revelli","year":"2013","unstructured":"Revelli A, Porcu E, Levi Setti PE, Delle Piane L, Merlo DF, Anserini P (2013) Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer? Gynecol Endocrinol 29:993\u2013996. https:\/\/doi.org\/10.3109\/09513590.2013.819083","journal-title":"Gynecol Endocrinol"},{"key":"4594_CR24","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1200\/JCO.2014.59.3723","volume":"33","author":"K Oktay","year":"2015","unstructured":"Oktay K, Turan V, Bedoschi G, Pacheco FS, Moy F (2015) Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer. J Clin Oncol 33:2424\u20132429. https:\/\/doi.org\/10.1200\/JCO.2014.59.3723","journal-title":"J Clin Oncol"},{"key":"4594_CR25","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1210\/jc.2015-3878","volume":"101","author":"J Kim","year":"2016","unstructured":"Kim J, Turan V, Oktay K (2016) Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer. J Clin Endocrinol Metab 101:1364\u20131371. https:\/\/doi.org\/10.1210\/jc.2015-3878","journal-title":"J Clin Endocrinol Metab"},{"key":"4594_CR26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1200\/JCO.2012.44.3721","volume":"31","author":"K Behringer","year":"2013","unstructured":"Behringer K, Mueller H, Goergen H, Thielen I, Eibl AD, Stumpf V, Wessels C, Wiehlputz M, Rosenbrock J, Halbsguth T, Reiners KS, Schober T, Renno JH, von Wolff M, van der Ven K, Kuehr M, Fuchs M, Diehl V, Engert A, Borchmann P (2013) Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin study group HD13 to HD15 Trials. J Clin Oncol 31:231\u2013239","journal-title":"J Clin Oncol"},{"key":"4594_CR27","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ajh.24184","volume":"90","author":"I Glimelius","year":"2015","unstructured":"Glimelius I, Ekberg S, Jerkeman M, Chang ET, Bjorkholm M, Andersson TM, Smedby KE, Eloranta S (2015) Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992\u20132009-trends in cure proportions by clinical characteristics. Am J Hematol 90:1128\u20131134","journal-title":"Am J Hematol"},{"key":"4594_CR28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00000421-199708000-00006","volume":"20","author":"SS Kulkarni","year":"1997","unstructured":"Kulkarni SS, Sastry PS, Saikia TK, Parikh PM, Gopal R, Advani SH (1997) Gonadal function following ABVD therapy for Hodgkin\u2019s disease. Am J Clin Oncol 20:354\u2013357","journal-title":"Am J Clin Oncol"},{"key":"4594_CR29","doi-asserted-by":"crossref","first-page":"7555","DOI":"10.1200\/JCO.2005.08.138","volume":"23","author":"K Behringer","year":"2005","unstructured":"Behringer K, Breuer K, Reineke T, May M, Nogova L, Klimm B, Schmitz T, Wildt L, Diehl V, Engert A, German Hodgkin\u2019s Lymphoma Study Group (2005) Secondary amenorrhea after Hodgkin\u2019s lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin\u2019s Lymphoma Study Group. J Clin Oncol 23:7555\u20137564","journal-title":"J Clin Oncol"},{"key":"4594_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1182\/blood-2007-05-090225","volume":"111","author":"ML Bruin De","year":"2008","unstructured":"De Bruin ML, Huisbrink J, Hauptmann M, Kuenen MA, Ouwens GM, van\u2019t Veer MB, Aleman BM, van Leeuwen FE (2008) Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood 111:101\u2013108","journal-title":"Blood"},{"key":"4594_CR31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/sj.bjc.6603050","volume":"94","author":"T Seshadri","year":"2006","unstructured":"Seshadri T, Gook D, Lade S, Spencer A, Grigg A, Tiedemann K, McKendrick J, Mitchell P, Stern C, Seymour JF (2006) Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield. Br J Cancer 94:1007\u20131010","journal-title":"Br J Cancer"},{"key":"4594_CR32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/humrep\/den055","volume":"23","author":"D Meirow","year":"2008","unstructured":"Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra\u2019anani H, Slyusarevsky E, Amariglio N, Schiff E, Rechavi G, Nagler A, Ben Yehuda D (2008) Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 23:1007\u20131013","journal-title":"Hum Reprod"},{"issue":"803","key":"4594_CR33","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.fertnstert.2010.07.1068","volume":"95","author":"SE Bittinger","year":"2011","unstructured":"Bittinger SE, Nazaretian SP, Gook DA, Parmar C, Harrup RA, Stern CJ (2011) Detection of Hodgkin lymphoma within ovarian tissue. Fertil Steril 95(803):e3\u2013e6. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.07.1068","journal-title":"Fertil Steril"},{"key":"4594_CR34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3802\/jgo.2015.26.4.343","volume":"26","author":"SJ Seong","year":"2015","unstructured":"Seong SJ, Kim DH, Kim MK, Song T (2015) Controversies in borderline ovarian tumors. J Gynecol Oncol 26:343\u2013349","journal-title":"J Gynecol Oncol"},{"key":"4594_CR35","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.ejca.2013.01.035","volume":"49","author":"A Bois du","year":"2013","unstructured":"du Bois A, Ewald-Riegler N, de Gregorio N, Reuss A, Mahner S, Fotopoulou C, Kommoss F, Schmalfeldt B, Hilpert F, Fehm T, Burges A, Meier W, Hillemanns P, Hanker L, Hasenburg A, Strauss HG, Hellriegel M, Wimberger P, Keyver-Paik MD, Baumann K, Canzler U, Wollschlaeger K, Forner D, Pfisterer J, Schr\u00f6der W, M\u00fcnstedt K, Richter B, Kommoss S, Hauptmann S, Arbeitsgemeinschaft Gyn\u00e4kologische Onkologie (AGO) Study Group (2013) Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gyn\u00e4kologische Onkologie (AGO) Study Group. Eur J Cancer 49:1905\u20131914. https:\/\/doi.org\/10.1016\/j.ejca.2013.01.035","journal-title":"Eur J Cancer"},{"key":"4594_CR36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/annonc\/mdp267","volume":"21","author":"C Uzan","year":"2010","unstructured":"Uzan C, Kane A, Rey A, Gouy S, Duvillard P, Morice P (2010) Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary. Ann Oncol 21:55\u201360","journal-title":"Ann Oncol"},{"key":"4594_CR37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.fertnstert.2004.10.009","volume":"83","author":"R Fauvet","year":"2005","unstructured":"Fauvet R, Poncelet C, Boccara J, Descamps P, Fondrinier E, Darai E (2005) Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study. Fertil Steril 83:284\u2013290","journal-title":"Fertil Steril"},{"key":"4594_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ctrv.2016.06.010","volume":"49","author":"G Mangili","year":"2016","unstructured":"Mangili G, Somigliana E, Giorgione V, Martinelli F, Filippi F, Petrella MC, Candiani M, Peccatori F (2016) Fertility preservation in women with borderline ovarian tumours. Cancer Treat Rev 49:13\u201324. https:\/\/doi.org\/10.1016\/j.ctrv.2016.06.010","journal-title":"Cancer Treat Rev"},{"key":"4594_CR39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ygyno.2006.05.014","volume":"103","author":"E Suh-Burgmann","year":"2006","unstructured":"Suh-Burgmann E (2006) Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Gynecol Oncol 103:841\u2013847","journal-title":"Gynecol Oncol"},{"key":"4594_CR40","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/annonc\/mdu119","volume":"25","author":"F Trillsch","year":"2014","unstructured":"Trillsch F, Mahner S, Woelber L, Vettorazzi E, Reuss A, Ewald-Riegler N, de Gregorio N, Fotopoulou C, Schmalfeldt B, Burges A, Hilpert F, Fehm T, Meier W, Hillemanns P, Hanker L, Hasenburg A, Strauss HG, Hellriegel M, Wimberger P, Baumann K, Keyver-Paik MD, Canzler U, Wollschlaeger K, Forner D, Pfisterer J, Schroeder W, Muenstedt K, Richter B, Kommoss F, Hauptmann S, du Bois A (2014) Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study. Ann Oncol 25:1320\u20131327","journal-title":"Ann Oncol"},{"key":"4594_CR41","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1002\/cncr.24461","volume":"115","author":"JD Wright","year":"2009","unstructured":"Wright JD, Shah M, Mathew L, Burke WM, Culhane J, Goldman N, Schiff PB, Herzog TJ (2009) Fertility preservation in young women with epithelial ovarian cancer. Cancer 115:4118\u20134126","journal-title":"Cancer"},{"key":"4594_CR42","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.fertnstert.2015.06.008","volume":"104","author":"E Bentivegna","year":"2015","unstructured":"Bentivegna E, Fruscio R, Roussin S, Ceppi L, Satoh T, Kajiyama H, Uzan C, Colombo N, Gouy S, Morice P (2015) Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients. Fertil Steril 104:1319\u20131324. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.06.008","journal-title":"Fertil Steril"},{"key":"4594_CR43","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/bjc.2016.254","volume":"115","author":"R Fruscio","year":"2016","unstructured":"Fruscio R, Ceppi L, Corso S, Galli F, Dell\u2019Anna T, Dell\u2019Orto F, Giuliani D, Garbi A, Chiari S, Mangioni C, Milani R, Floriani I, Colombo N, Bonazzi CM (2016) Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer. Br J Cancer 115:641\u2013648. https:\/\/doi.org\/10.1038\/bjc.2016.254","journal-title":"Br J Cancer"},{"key":"4594_CR44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000316264","volume":"70","author":"D Denschlag","year":"2010","unstructured":"Denschlag D, von Wolff M, Amant F, Kesic V, Reed N, Schneider A, Rodolakis A (2010) Clinical recommendation on fertility preservation in borderline ovarian neoplasm: ovarian stimulation and oocyte retrieval after conservative surgery. Gynecol Obstet Invest 70:160\u2013165. https:\/\/doi.org\/10.1159\/000316264","journal-title":"Gynecol Obstet Invest"},{"key":"4594_CR45","doi-asserted-by":"publisher","first-page":"CD008215","DOI":"10.1002\/14651858.CD008215.pub2","volume":"8","author":"I Rizzuto","year":"2013","unstructured":"Rizzuto I, Behrens RF, Smith LA (2013) Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database Syst Rev 8:CD008215. https:\/\/doi.org\/10.1002\/14651858.CD008215.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"4594_CR46","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ijrobp.2004.11.038","volume":"62","author":"WH Wallace","year":"2005","unstructured":"Wallace WH, Thomson AB, Saran F, Kelsey TW (2005) Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 62:738\u2013744","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4594_CR47","doi-asserted-by":"publisher","first-page":"482968","DOI":"10.1155\/2014\/482968","volume":"2014","author":"WT Teh","year":"2014","unstructured":"Teh WT, Stern C, Chander S, Hickey M (2014) The impact of uterine radiation on subsequent fertility and pregnancy outcomes. Biomed Res Int 2014:482968. https:\/\/doi.org\/10.1155\/2014\/482968","journal-title":"Biomed Res Int"},{"key":"4594_CR48","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1006\/gyno.2001.6277","volume":"82","author":"R Yamamoto","year":"2001","unstructured":"Yamamoto R, Okamoto K, Yukiharu T, Kaneuchi M, Negishi H, Sakuragi N, Fujimoto S (2001) A study of risk factors for ovarian metastases in stage Ib\u2013IIIb cervical carcinoma and analysis of ovarian function after a transposition. Gynecol Oncol 82:312\u2013316","journal-title":"Gynecol Oncol"},{"key":"4594_CR49","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1097\/PAS.0b013e3181758831","volume":"32","author":"BM Ronnett","year":"2008","unstructured":"Ronnett BM, Yemelyanova AV, Vang R, Gilks CB, Miller D, Gravitt PE, Kurman RJ (2008) Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms. Am J Surg Pathol 32:1835\u20131853","journal-title":"Am J Surg Pathol"},{"key":"4594_CR50","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/humupd\/dmt020","volume":"19","author":"L Bastings","year":"2013","unstructured":"Bastings L, Beerendonk CC, Westphal JR, Massuger LF, Kaal SE, van Leeuwen FE, Braat DD, Peek R (2013) Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. Hum Reprod Update 19:483\u2013506","journal-title":"Hum Reprod Update"},{"key":"4594_CR51","doi-asserted-by":"crossref","first-page":"g6192","DOI":"10.1136\/bmj.g6192","volume":"349","author":"M Kyrgiou","year":"2014","unstructured":"Kyrgiou M, Mitra A, Arbyn M, Stasinou SM, Martin-Hirsch P, Bennett P, Paraskevaidis E (2014) Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis. BMJ 349:g6192","journal-title":"BMJ"},{"key":"4594_CR52","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/AOG.0b013e3181d06b68","volume":"115","author":"JD Wright","year":"2010","unstructured":"Wright JD, NathavithArana R, Lewin SN, Sun X, Deutsch I, Burke WM, Herzog TJ (2010) Fertility-conserving surgery for young women with stage IA1 cervical cancer: safety and access. Obstet Gynecol 115:585\u2013590. https:\/\/doi.org\/10.1097\/AOG.0b013e3181d06b68","journal-title":"Obstet Gynecol"},{"key":"4594_CR53","doi-asserted-by":"publisher","first-page":"80.e1","DOI":"10.1016\/j.ajog.2011.07.029","volume":"206","author":"L Spoozak","year":"2012","unstructured":"Spoozak L, Lewin SN, Burke WM, Deutsch I, Sun X, Herzog TJ, Wright JD (2012) Microinvasive adenocarcinoma of the cervix. Am J Obstet Gynecol 206:80.e1\u201380.e6. https:\/\/doi.org\/10.1016\/j.ajog.2011.07.029","journal-title":"Am J Obstet Gynecol"},{"key":"4594_CR54","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1877::AID-CNCR17>3.0.CO;2-W","volume":"88","author":"D D\u2019argent","year":"2000","unstructured":"D\u2019argent D, Martin X, Sacchetoni A, Mathevet P (2000) Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients. Cancer 88:1877\u20131882","journal-title":"Cancer"},{"key":"4594_CR55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2012.05.033","volume":"126","author":"GF Vercellino","year":"2012","unstructured":"Vercellino GF, Piek JM, Schneider A, Kohler C, Mangler M, Speiser D, Chiantera V (2012) Laparoscopic lymph node dissection should be performed before fertility preserving treatment of patients with cervical cancer. Gynecol Oncol 126:325\u2013329","journal-title":"Gynecol Oncol"},{"key":"4594_CR56","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ygyno.2016.07.008","volume":"142","author":"J Slama","year":"2016","unstructured":"Slama J, Cerny A, Dusek L, Fischerova D, Zikan M, Kocian R, Germanova A, Cibula D (2016) Results of less radical fertility-sparing procedures with omitted parametrectomy for cervical cancer: 5\u00a0years of experience. Gynecol Oncol 142:401\u2013404. https:\/\/doi.org\/10.1016\/j.ygyno.2016.07.008","journal-title":"Gynecol Oncol"},{"key":"4594_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmv066","author":"I Zapardiel","year":"2016","unstructured":"Zapardiel I, Cruz M, Diestro MD, Requena A, Garcia-Velasco JA (2016) Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers. Hum Reprod Update. https:\/\/doi.org\/10.1093\/humupd\/dmv066","journal-title":"Hum Reprod Update"},{"key":"4594_CR58","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/IGC.0000000000000231","volume":"24","author":"J Lyu","year":"2014","unstructured":"Lyu J, Sun T, Tan X (2014) Ovarian preservation in young patients with stage I cervical adenocarcinoma: a surveillance, epidemiology, and end results study. Int J Gynecol Cancer 24:1513\u20131520","journal-title":"Int J Gynecol Cancer"},{"key":"4594_CR59","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ygyno.2014.08.021","volume":"135","author":"H Robova","year":"2014","unstructured":"Robova H, Halaska MJ, Pluta M, Skapa P, Matecha J, Lisy J, Rob L (2014) Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer. Gynecol Oncol 135:213\u2013216","journal-title":"Gynecol Oncol"},{"issue":"1195\u20131211","key":"4594_CR60","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.fertnstert.2016.06.032","volume":"106","author":"E Bentivegna","year":"2016","unstructured":"Bentivegna E, Maulard A, Pautier P, Chargari C, Gouy S, Morice P (2016) Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature. Fertil Steril 106(1195\u20131211):e5. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.06.032","journal-title":"Fertil Steril"},{"key":"4594_CR61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40661-016-0030-9","volume":"3","author":"K Willows","year":"2016","unstructured":"Willows K, Lennox G, Covens A (2016) Fertility-sparing management in cervical cancer: balancing oncologic outcomes with reproductive success. Gynecol Oncol Res Pract 3:9 (eCollection 2016)","journal-title":"Gynecol Oncol Res Pract"},{"key":"4594_CR62","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s10147-016-1059-9","volume":"22","author":"K Okugawa","year":"2017","unstructured":"Okugawa K, Kobayashi H, Sonoda K, Kaneki E, Kawano Y, Hidaka N, Egashira K, Fujita Y, Yahata H, Kato K (2017) Oncologic and obstetric outcomes and complications during pregnancy after fertility-sparing abdominal trachelectomy for cervical cancer: a retrospective review. Int J Clin Oncol 22:340\u2013346. https:\/\/doi.org\/10.1007\/s10147-016-1059-9","journal-title":"Int J Clin Oncol"},{"key":"4594_CR63","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3892\/mco.2016.972","volume":"5","author":"Y Feng","year":"2016","unstructured":"Feng Y, Cao T, Wang Y, Huang H, Xie Y, Liu J (2016) Neoadjuvant chemotherapy followed by conization to spare fertility in cases of locally advanced cervical cancer: a case report and review of the literature. Mol Clin Oncol 5:411\u2013416","journal-title":"Mol Clin Oncol"},{"key":"4594_CR64","first-page":"3418","volume":"19","author":"B Mossa","year":"2015","unstructured":"Mossa B, Schimberni M, Di Benedetto L, Mossa S (2015) Ovarian transposition in young women and fertility sparing. Eur Rev Med Pharmacol Sci 19:3418\u20133425","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4594_CR65","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/aogs.12588","volume":"94","author":"Y Kinjyo","year":"2015","unstructured":"Kinjyo Y, Kudaka W, Ooyama T, Inamine M, Nagai Y, Aoki Y (2015) Ovarian preservation in young women with endometrial cancer of endometrioid histology. Acta Obstet Gynecol Scand 94:430\u2013434. https:\/\/doi.org\/10.1111\/aogs.12588","journal-title":"Acta Obstet Gynecol Scand"},{"key":"4594_CR66","doi-asserted-by":"crossref","first-page":"969","DOI":"10.21873\/anticanres.11406","volume":"37","author":"A Dogan","year":"2017","unstructured":"Dogan A, Schultheis B, Rezniczek GA, Hilal Z, Cetin C, H\u00e4usler G, Tempfer CB (2017) Synchronous endometrial and ovarian cancer in young women: case report and review of the literature. Anticancer Res 37:969\u2013978","journal-title":"Anticancer Res"},{"key":"4594_CR67","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00404-013-2826-8","volume":"288","author":"BE Shan","year":"2013","unstructured":"Shan BE, Ren YL, Sun JM, Tu XY, Jiang ZX, Ju XZ, Zang RY, Wang HY (2013) A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women. Arch Gynecol Obstet 288:1115\u20131123","journal-title":"Arch Gynecol Obstet"},{"key":"4594_CR68","doi-asserted-by":"crossref","first-page":"358.e1","DOI":"10.1016\/j.ajog.2013.06.031","volume":"209","author":"MK Kim","year":"2013","unstructured":"Kim MK, Seong SJ, Kim YS, Song T, Kim ML, Yoon BS, Jun HS, Lee YH (2013) Combined medroxyprogesterone acetate\/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer. Am J Obstet Gynecol 209:358.e1\u2013358.e4","journal-title":"Am J Obstet Gynecol"},{"key":"4594_CR69","first-page":"691","volume":"6","author":"E Kalogera","year":"2014","unstructured":"Kalogera E, Dowdy SC, Bakkum-Gamez JN (2014) Preserving fertility in young patients with endometrial cancer: current perspectives. Int J Womens Health 6:691\u2013701","journal-title":"Int J Womens Health"},{"key":"4594_CR70","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/IGC.0000000000000467","volume":"25","author":"SM Pronin","year":"2015","unstructured":"Pronin SM, Novikova OV, Andreeva JY, Novikova EG (2015) Fertility-sparing treatment of early endometrial cancer and complex atypical hyperplasia in young women of childbearing potential. Int J Gynecol Cancer 25:1010\u20131014","journal-title":"Int J Gynecol Cancer"},{"key":"4594_CR71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1684\/bdc.2011.1521","volume":"99","author":"M Poilblanc","year":"2012","unstructured":"Poilblanc M, Samouelian V, Querleu D (2012) Ovarian preservation during treatment of early stage endometrial cancer. Bull Cancer 99:61\u201368","journal-title":"Bull Cancer"},{"key":"4594_CR72","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ygyno.2009.08.011","volume":"115","author":"O Zivanovic","year":"2009","unstructured":"Zivanovic O, Carter J, Kauff ND, Barakat RR (2009) A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer. Gynecol Oncol 115:504\u2013509","journal-title":"Gynecol Oncol"},{"key":"4594_CR73","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ygyno.2013.08.024","volume":"131","author":"TS Lee","year":"2013","unstructured":"Lee TS, Lee JY, Kim JW, Oh S, Seong SJ, Lee JM, Kim TJ, Cho CH, Kim SM, Park CY (2013) Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study. Gynecol Oncol 131:289\u2013293","journal-title":"Gynecol Oncol"},{"key":"4594_CR74","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/AOG.0000000000001181","volume":"127","author":"JD Wright","year":"2016","unstructured":"Wright JD, Jorge S, Tergas AI, Hou JY, Burke WM, Huang Y, Hu JC, Ananth CV, Neugut AI, Hershman DL (2016) Utilization and outcomes of ovarian conservation in premenopausal women with endometrial cancer. Obstet Gynecol 127:101\u2013108. https:\/\/doi.org\/10.1097\/AOG.0000000000001181","journal-title":"Obstet Gynecol"},{"key":"4594_CR75","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1634\/theoncologist.2013-0445","volume":"20","author":"JY Park","year":"2015","unstructured":"Park JY, Nam JH (2015) Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer. Oncologist 20:270\u2013278","journal-title":"Oncologist"},{"key":"4594_CR76","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12958-015-0136-7","volume":"14","author":"O Inoue","year":"2016","unstructured":"Inoue O, Hamatani T, Susumu N, Yamagami W, Ogawa S, Takemoto T, Hirasawa A, Banno K, Kuji N, Tanaka M, Aoki D (2016) Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia. Reprod Biol Endocrinol 14:2. https:\/\/doi.org\/10.1186\/s12958-015-0136-7","journal-title":"Reprod Biol Endocrinol"},{"key":"4594_CR77","first-page":"2129","volume":"29","author":"JP Ioannidis","year":"2002","unstructured":"Ioannidis JP, Katsifis GE, Tzioufas AG, Moutsopoulos HM (2002) Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J Rheumatol 29:2129\u20132135","journal-title":"J Rheumatol"},{"key":"4594_CR78","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1191\/0961203304lu1063oa","volume":"13","author":"MC Park","year":"2004","unstructured":"Park MC, Park YB, Jung SY, Sbai A, Costedoat N, Wechsler B, Piette JC (2004) Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy. Lupus 13:569\u2013574","journal-title":"Lupus"},{"key":"4594_CR79","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/rheumatology\/kev124","volume":"54","author":"M Henes","year":"2015","unstructured":"Henes M, Froeschlin J, Taran FA, Brucker S, Rall KK, Xenitidis T, Igney-Oertel A, Lawrenz B, Henes J (2015) Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Behcet\u2019s disease and spondyloarthritis on anti-Mullerian hormone levels. Rheumatology (Oxford) 54:1709\u20131712","journal-title":"Rheumatology (Oxford)"},{"key":"4594_CR80","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1177\/0961203311409272","volume":"20","author":"B Lawrenz","year":"2011","unstructured":"Lawrenz B, Henes J, Henes M, Neunhoeffer E, Schmalzing M, Fehm T, Kotter I (2011) Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone. Lupus 20:1193\u20131197","journal-title":"Lupus"},{"key":"4594_CR81","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3899\/jrheum.131360","volume":"41","author":"AR Mont\u2019Alverne","year":"2014","unstructured":"Mont\u2019Alverne AR, Pereira RM, Yamakami L, Viana VS, Baracat EC, Bonfa E, Silva CA (2014) Reduced ovarian reserve in patients with takayasu arteriitis. J Rheumatol 41:2055\u20132059","journal-title":"J Rheumatol"},{"key":"4594_CR82","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","volume":"76","author":"L Andreoli","year":"2017","unstructured":"Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF, Khamashta M, King J, Lojacono A, Marchiori F, Meroni PL, Mosca M, Motta M, Ostensen M, Pamfil C, Raio L, Schneider M, Svenungsson E, Tektonidou M, Yavuz S, Boumpas D, Tincani A (2017) EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome. Ann Rheum Dis 76:476\u2013485. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209770","journal-title":"Ann Rheum Dis"},{"key":"4594_CR83","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/1529-0131(199906)42:6<1274::AID-ANR26>3.0.CO;2-B","volume":"42","author":"CC Mok","year":"1999","unstructured":"Mok CC, Wong RW, Lau CS (1999) Ovarian failure and flares of systemic lupus erythematosus. Arthritis Rheum 42:1274\u20131280","journal-title":"Arthritis Rheum"},{"issue":"8","key":"4594_CR84","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fendo.2017.00069","volume":"10","author":"M Wolff von","year":"2017","unstructured":"von Wolff M, Stute P (2017) Judging the fertility protective effect of GnRH agonists in chemotherapy\u2014it is a matter of perspective. Front Endocrinol (Lausanne) 10(8):69. https:\/\/doi.org\/10.3389\/fendo.2017.00069","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4594_CR85","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.fertnstert.2007.12.044","volume":"91","author":"A Badawy","year":"2009","unstructured":"Badawy A, Elnashar A, El-Ashry M, Shahat M (2009) Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril 91:694\u2013697","journal-title":"Fertil Steril"},{"key":"4594_CR86","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/art.21263","volume":"52","author":"EC Somers","year":"2005","unstructured":"Somers EC, Marder W, Christman GM, Ognenovski V, McCune WJ (2005) Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. Arthritis Rheum 52:2761\u20132767","journal-title":"Arthritis Rheum"},{"key":"4594_CR87","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120300678828596","volume":"9","author":"Z Blumenfeld","year":"2009","unstructured":"Blumenfeld Z, Shapiro D, Shteinberg M, Avivi I, Nahir M (2009) Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus 9:401\u2013405","journal-title":"Lupus"},{"key":"4594_CR88","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3109\/09513590.2011.650752","volume":"28","author":"W Marder","year":"2012","unstructured":"Marder W, McCune WJ, Wang L, Wing JJ, Fisseha S, McConnell DS, Christman GM, Somers EC (2012) Adjunctive GnRH\u2014a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients. Gynecol Endocrinol 28:624\u2013627","journal-title":"Gynecol Endocrinol"},{"key":"4594_CR89","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200003)43:3<550::AID-ANR10>3.0.CO;2-Y","volume":"43","author":"N Guballa","year":"2000","unstructured":"Guballa N, Sammaritano L, Schwartzman S, Buyon J, Lockshin MD (2000) Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 43:550\u2013556","journal-title":"Arthritis Rheum"},{"key":"4594_CR90","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2013.11.004","volume":"13","author":"Q Reynaud","year":"2014","unstructured":"Reynaud Q, Lega JC, Mismetti P, Chapelle C, Wahl D, Cathebras P, Laporte S (2014) Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis. Autoimmun Rev 13:595\u2013608","journal-title":"Autoimmun Rev"},{"key":"4594_CR91","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/pbc.25304","volume":"62","author":"A Raciborska","year":"2015","unstructured":"Raciborska A, Bilska K, Filipp E, Drabko K, Rogowska E, Chaber R, Pogorza\u0142a M, Po\u0142czy\u0144ska K, Adrianowska N, Rodriguez-Galindo C, Maciejewski T (2015) Ovarian function in female survivors after multimodal Ewing sarcoma therapy. Pediatr Blood Cancer 62:341\u2013345. https:\/\/doi.org\/10.1002\/pbc.25304","journal-title":"Pediatr Blood Cancer"},{"key":"4594_CR92","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.ejca.2013.01.032","volume":"49","author":"T Greve","year":"2013","unstructured":"Greve T, Wielenga VT, Grauslund M, Sorensen N, Christiansen DB, Rosendahl M, Yding Andersen C (2013) Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contamination. Eur J Cancer 49:1932\u20131938","journal-title":"Eur J Cancer"},{"key":"4594_CR93","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/humrep\/deq121","volume":"25","author":"R Abir","year":"2010","unstructured":"Abir R, Feinmesser M, Yaniv I, Fisch B, Cohen IJ, Ben-Haroush A, Meirow D, Felz C, Avigad S (2010) Occasional involvement of the ovary in Ewing sarcoma. Hum Reprod 25:1708\u20131712","journal-title":"Hum Reprod"},{"key":"4594_CR94","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2217\/fon.13.183","volume":"10","author":"SD Sorensen","year":"2014","unstructured":"Sorensen SD, Greve T, Wielenga VT, Wallace WH, Andersen CY (2014) Safety considerations for transplanting cryopreserved ovarian tissue to restore fertility in female patients who have recovered from Ewing\u2019s sarcoma. Future Oncol 10:277\u2013283","journal-title":"Future Oncol"},{"key":"4594_CR95","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1093\/humrep\/dew193","volume":"31","author":"MM Dolmans","year":"2016","unstructured":"Dolmans MM, Iwahara Y, Donnez J, Soares M, Vaerman JL, Amorim CA, Poirel H (2016) Evaluation of minimal disseminated disease in cryopreserved ovarian tissue from bone and soft tissue sarcoma patients. Hum Reprod 31:2292\u20132302. https:\/\/doi.org\/10.1093\/humrep\/dew193","journal-title":"Hum Reprod"},{"key":"4594_CR96","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1470-2045(13)70288-2","volume":"14","author":"S Irtan","year":"2013","unstructured":"Irtan S, Orbach D, Helfre S, Sarnacki S (2013) Ovarian transposition in prepubescent and adolescent girls with cancer. Lancet Oncol 14:601\u2013608","journal-title":"Lancet Oncol"},{"key":"4594_CR97","first-page":"151","volume":"10","author":"A Longhi","year":"2003","unstructured":"Longhi A, Pignotti E, Versari M, Asta S, Bacci G (2003) Effect of oral contraceptive on ovarian function in young females undergoing neoadjuvant chemotherapy treatment for osteosarcoma. Oncol Rep 10:151\u2013155","journal-title":"Oncol Rep"},{"key":"4594_CR98","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.amjsurg.2007.08.031","volume":"194","author":"M Strong","year":"2007","unstructured":"Strong M, Peche W, Scaife C (2007) Incidence of fertility counseling of women of child-bearing age before treatment for colorectal cancer. Am J Surg 194:765\u2013767 (discussion 767\u2013768)","journal-title":"Am J Surg"},{"key":"4594_CR99","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/DCR.0b013e31820240b3","volume":"54","author":"MT O\u2019Neill","year":"2011","unstructured":"O\u2019Neill MT, Ni Dhonnchu T, Brannigan AE (2011) Topic update: effects of colorectal cancer treatments on female fertility and potential methods for fertility preservation. Dis Colon Rectum 54:363\u2013369","journal-title":"Dis Colon Rectum"},{"key":"4594_CR100","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clcc.2014.09.012","volume":"14","author":"J Wan","year":"2015","unstructured":"Wan J, Gai Y, Li G, Tao Z, Zhang Z (2015) Incidence of chemotherapy- and chemoradiotherapy-induced amenorrhea in premenopausal women with stage II\/III colorectal cancer. Clin Colorectal Cancer 14:31\u201334. https:\/\/doi.org\/10.1016\/j.clcc.2014.09.012","journal-title":"Clin Colorectal Cancer"},{"key":"4594_CR101","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/10428190500353877","volume":"47","author":"A Elis","year":"2006","unstructured":"Elis A, Tevet A, Yerushalmi R, Blickstein D, Bairy O, Dann EJ, Blumenfeld Z, Abraham A, Manor Y, Shpilberg O, Lishner M (2006) Fertility status among women treated for aggressive non-Hodgkin\u2019s lymphoma. Leuk Lymphoma 47:623\u2013627","journal-title":"Leuk Lymphoma"},{"key":"4594_CR102","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/sj.bmt.1705364","volume":"37","author":"A Carter","year":"2006","unstructured":"Carter A, Robison LL, Francisco L, Smith D, Grant M, Baker KS, Gurney JG, McGlave PB, Weisdorf DJ, Forman SJ, Bhatia S (2006) Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transpl 37:1023\u20131029","journal-title":"Bone Marrow Transpl"},{"key":"4594_CR103","first-page":"212","volume":"82","author":"AA Briseno-Hernandez","year":"2014","unstructured":"Briseno-Hernandez AA, Quezada-Lopez DR, Castaneda-Chavez A, Dassaejv Macias-Amezcua M, Pintor-Belmontes JC (2014) Bilateral ovarian Burkitt\u2019s lymphoma. A case presentation. Cir Cir 82:212\u2013218","journal-title":"Cir Cir"},{"key":"4594_CR104","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10815-012-9792-0","volume":"29","author":"P Jadoul","year":"2012","unstructured":"Jadoul P, Kim SS, ISFP Practice Committee (2012) Fertility considerations in young women with hematological malignancies. J Assist Reprod Genet 29:479\u2013487. https:\/\/doi.org\/10.1007\/s10815-012-9792-0","journal-title":"J Assist Reprod Genet"},{"key":"4594_CR105","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.6004\/jnccn.2015.0153","volume":"10","author":"JC Alvarnas","year":"2015","unstructured":"Alvarnas JC, Brown PA, Aoun P, Ballen KK, Barta SK, Borate U, Boyer MW, Burke PW, Cassaday R, Castro JE, Coccia PF, Coutre SE, Damon LE, DeAngelo DJ, Douer D, Frankfurt O, Greer JP, Johnson RA, Kantarjian HM, Klisovic RB, Kupfer G, Litzow M, Liu A, Rao AV, Shah B, Uy GL, Wang ES, Zelenetz AD, Gregory K, Smith C (2015) Acute lymphoblastic leukemia, version 2.2015. J Natl Compr Canc Netw 10:1240\u20131279","journal-title":"J Natl Compr Canc Netw"},{"key":"4594_CR106","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2010-01-265751","volume":"116","author":"MM Dolmans","year":"2010","unstructured":"Dolmans MM, Marinescu C, Saussoy P, Van Langendonckt A, Amorim C, Donnez J (2010) Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood 116:2908\u20132914","journal-title":"Blood"},{"key":"4594_CR107","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10815-012-9786-y","volume":"29","author":"ISFP Practice Committee","year":"2012","unstructured":"Practice Committee ISFP, Kim SS, Donnez J, Barri P, Pellicer A, Patrizio P, Rosenwaks Z, Nagy P, Falcone T, Andersen C, Hovatta O, Wallace H, Meirow D, Gook D, Kim SH, Tzeng CR, Suzuki S, Ishizuka B, Dolmans MM (2012) Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet 29:465\u2013468. https:\/\/doi.org\/10.1007\/s10815-012-9786-y","journal-title":"J Assist Reprod Genet"},{"key":"4594_CR108","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(01)05482-4","volume":"358","author":"N Salooja","year":"2001","unstructured":"Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Ljungman P, Van Lint MT, Powles R, Jackson G, Hinterberger-Fischer M, Kolb HJ, Apperley JF, Late Effects Working Party of the European Group for Blood and Marrow Transplantation (2001) Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 358:271\u2013276","journal-title":"Lancet"},{"key":"4594_CR109","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.clon.2012.03.006","volume":"24","author":"P Hurmuz","year":"2012","unstructured":"Hurmuz P, Sebag-Montefiore D, Byrne P, Cooper R (2012) Successful spontaneous pregnancy after pelvic chemoradiotherapy for anal cancer. Clin Oncol (R Coll Radiol) 24:455\u2013457","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"4594_CR110","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/01443610701535766","volume":"27","author":"E Menezes De","year":"2007","unstructured":"De Menezes E, Tuck SM (2007) Pelvic radiotherapy damage to the endometrium causing morbid adherence of placenta. A new risk factor? J Obstet Gynaecol 27:526\u2013527","journal-title":"J Obstet Gynaecol"},{"key":"4594_CR111","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/humrep\/deh472","volume":"19","author":"LE Bath","year":"2004","unstructured":"Bath LE, Tydeman G, Critchley HO, Anderson RA, Baird DT, Wallace WH (2004) Spontaneous conception in a young woman who had ovarian cortical tissue cryopreserved before chemotherapy and radiotherapy for a Ewing\u2019s sarcoma of the pelvis: case report. Hum Reprod 19:2569\u20132572","journal-title":"Hum Reprod"},{"key":"4594_CR112","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/humrep\/deg016","volume":"18","author":"WH Wallace","year":"2003","unstructured":"Wallace WH, Thomson AB, Kelsey TW (2003) The radiosensitivity of the human oocyte. Hum Reprod 18:117\u2013121","journal-title":"Hum Reprod"},{"key":"4594_CR113","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s12094-016-1587-9","volume":"18","author":"M Mu\u00f1oz","year":"2016","unstructured":"Mu\u00f1oz M, Santaballa A, Segu\u00ed MA, Beato C, de la Cruz S, Espinosa J, Fonseca PJ, Perez J, Quintanar T, Blasco A (2016) SEOM Clinical Guideline of fertility preservation and reproduction in cancer patients. Clin Transl Oncol 18:1229\u20131236","journal-title":"Clin Transl Oncol"},{"key":"4594_CR114","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","volume":"24","author":"SJ Lee","year":"2006","unstructured":"Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K, American Society of Clinical Oncology (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917\u20132931","journal-title":"J Clin Oncol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-017-4594-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-017-4594-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-017-4594-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T19:09:23Z","timestamp":1570388963000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-017-4594-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,24]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["4594"],"URL":"https:\/\/doi.org\/10.1007\/s00404-017-4594-3","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,24]]}}}